<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940405-2-00070</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=11 g=1 f=1 --> a. Collect population-based information on race, incidence, staging at diagnosis, and mortality from breast and cervical cancers.  <!-- PJG 0012 frnewline --> b. Identify population segments at higher risk for disease and for failure to be screened.  <!-- PJG 0012 frnewline --> c. Identify factors that contribute to disease burden and limited or inequitable access to early detection and treatment services.  <!-- PJG 0012 frnewline --> d. Monitor the number and characteristics of women screened and outcomes of screening.  <!-- PJG 0012 frnewline --> e. Monitor screening resources, including the number of mammography facilities, cytology laboratories, and providers of cytology screening.  <!-- PJG 0012 frnewline --> f. Design and conduct case studies and other epidemiologic investigations to determine factors associated with avoidable morbidity and mortality.  <!-- PJG 0012 frnewline --> g. Publish a yearly report summarizing the population status with respect to these conditions.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> 6. Evaluation  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Attention should be given to the development, establishment, and design of individual components to ensure that there can be meaningful evaluation. The evaluation plan should assess the performance and effectiveness of intervention components, including:  <!-- PJG 0012 frnewline --> a. Coalition development.  <!-- PJG 0012 frnewline --> b. Cancer plan development.  <!-- PJG 0012 frnewline --> c. Public education.  <!-- PJG 0012 frnewline --> d. Professional education.  <!-- PJG 0012 frnewline --> e. Quality assurance.  <!-- PJG 0012 frnewline --> f. Surveillance.  <!-- PJG 0012 frnewline --> At a minimum, the evaluation plan should assess the existing State breast and cervical cancer control program and should include the following:  <!-- PJG 0012 frnewline --> a. A description of the evaluation plan and how evaluation results will be used.  <!-- PJG 0012 frnewline --> b. A description of methods used to assess the development of program activities in all program components.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> B. CDC Activities  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 1. Convene meetings for representatives of States receiving awards for workshops and sharing information.  <!-- PJG 0012 frnewline --> 2. Convene meetings for representatives of States receiving awards for training purposes.  <!-- PJG 0012 frnewline --> 3. Disseminate to State health departments relevant state-of-the-art research findings and public health recommendations that relate to early detection, diagnosis, and treatment for breast and cervical cancer. <!-- PJG 0012 frnewline --> 4. Collaborate with recipients in planning, operating, and evaluating program activities and coordinating projects' participation in all components of the cancer program.  <!-- PJG 0012 frnewline --> 5. Collaborate with recipients in developing surveillance and data systems and in the States' analysis and evaluation of data.  <!-- PJG 0012 frnewline --> 6. Provide technical assistance in the development of public and professional education components.  <!-- PJG 0012 frnewline --> 7. Collaborate with recipients in disseminating outcome indicators and their integration into program operation.  <!-- PJG 0012 frnewline --> 8. Provide guidance in the development and establishment of specific morbidity reduction objectives.  <!-- PJG 0012 frnewline --> 9. Provide technical information and guidelines in the development of quality assurance procedures for mammography and cervical cytology.  <!-- PJG 0012 frnewline --> 10. Provide technical assistance and direction in the development of evaluation efforts.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            